Vanda Pharmaceuticals announced its participation in several key healthcare investor conferences throughout November 2026, including events in New York City and London. The company will hold fireside chats at the Stifel 2026 Healthcare Conference and Jefferies Global Healthcare Conference, accessible live on its website. These presentations provide Vanda an opportunity to update investors on its progress and strategies in developing innovative therapies. Archived recordings will be available for about 30 days after each event.
Vanda Pharmaceuticals' November 2026 investor conference participation is noted here with Pluang's health sector market data as of Nov 04, 2026 04:11 WIB: Among 150 priced health-sector US stocks tradable on Pluang, 92 rose and 55 fell today. Top gainers included RVTY (Revvity Inc) at USD 164.46 with an 8.45% increase and 100% buy order activity, TWST (Twist Bioscience Corp) at USD 139.50 up 8.11%, and WGS (GeneDx Holdings Corp) at USD 68.89 rising 7.49%.
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
JELD-WEN Holding, Inc. reported a net loss of $17.2 million in Q3 2026, a significant improvement from a $367.6 million loss a year earlier, driven by tariff refunds, productivity gains, and cost reductions. Net revenues slightly declined by 1.4% to ...
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced its participation in several major healthcare conferences from November to December 2026. The company will engage in fireside chat...
Hormel Foods Corporation will release its fourth-quarter and full-year 2026 financial results on December 3, 2026, before market open. The company will also hold a webcast and conference call at 8 a.m. CT to discuss the results and provide an outlook...
